Skip to main content

Hepatocellular Mass Lesions: Old and New, Fun and Annoying



Original release date: June 2, 2021
Access to this course expires on:  March 14, 2024, at 11:59 PM Pacific Time
CME 1.5

Course Description
Six USCAP educators (recently vaccinated) traveled to Palm Springs to conduct interactive microscopy sessions broadcast live for the 2021 Virtual Annual Meeting with interactive Q&A, reflecting their academic expertise and experience. The Academy is pleased to offer access to Dr. John Hart’s study session with focus on the learning objectives below. Dr. Hart is Professor of Pathology at the University of Chicago. He is President-Elect of USCAP.

Learning Objectives
Upon completion of this educational activity, learners will be able to:
  • Recognize the key histologic features of the range of mass lesions composed of hepatocyes, including recently described entities
  • Understand the clinical, imaging and laboratory features that can aid in the proper diagnosis of hepatiocellular mass lesions
  • Appreciate the immunohistologic stains and molecular studies that confirm a diagnosis of various hepatocellular mass lesions

Target Audience
Practicing academic and community pathologists, and pathologists-in-training

Continuing Medical Education
The United States and Canadian Academy of Pathology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The United States and Canadian Academy of Pathology designates this enduring material for a maximum of 1.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Disclosures
The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to USCAP and to learners any financial relationship(s) that have occurred within the last 24 months with any commercial interest(s) whose products or services are related to the CME content. USCAP has reviewed all disclosures and mitigated all identified conflicts of interest, as applicable.

The following faculty reported no financial relationships: John Hart, MD

The following planners reported financial relationships:
Yuri Fedoriw: Consultant, Alexion Pharmaceuticals; Grant or Research Support, BioFluidica
Jason Hornick: Consultant, Eli Lilly, Epizyme, Aadi Bioscience
Liron Pantanowitz: Consultant, Hamamatsu; Advisory Board Member, Ibex

The following planners reported no relevant financial relationships: Zubair Baloch, Daniel Brat, Laura Collins, Sarah Dry, William Faquin, Karen Fritchie, Jennifer Gordetsky, Kristin Jensen, Melinda Lerwill, Anna Marie Mulligan, David Papke, Jr., Carlos Parra-Herran, Rajiv Patel, Deepa Patil, Charles Quick, Raja Seethala, Olga Weinberg, Ilan Weinreb, Maria Westerhoff, Rhonda Yantiss, Nicholas Zoumberos.

USCAP staff associated with the development of content for this activity reported no financial relationships.

To earn CME credit, all learners must complete the evaluation. Your certificate will be available to view and print by clicking here.

Not A Member? Click Here